Navigation Links
72% of Women Are Dissatisfied With Their Current Treatment of Vaginal Infection, Survey Finds
Date:5/13/2008

Foamix Offers New Intravaginal Foam Technology with Improved Usability &

Compliance

NESS ZIONA, Israel, May 13 /PRNewswire/ -- Despite the high incidence of women's health conditions that require intra-vaginal drug delivery and the abundance of intravaginal creams, gels and ovules, a recent survey found that an alarming majority of women find their current treatment options "unacceptable" or "intolerable". The survey, conducted by Elixir-Applied Researches for Foamix, polled more than 200 women.

Findings show that the majority of females who have used intravaginal drugs find them dissatisfying because these products leak out of the vagina following treatment (72%), because of irritation, itch or bad smell (60%), or simply because they are inconvenient to use (58%). 82% of the panellists opined that they would trade their current medication for a new form that does not leak; and 65% would prefer a product that does not cause irritation, itch or bad smell.

Foamix develops foam delivery systems for intravaginal administration that expand gently in the vaginal cavity and evenly cover the entire vaginal surface for efficient treatment. The Foamix foams are administered in small and accurate amounts, (using metered dose valves). They are bioadhesive to reduce dosing frequency and are constituted of non-irritating ingredients. Notably, the Foamix foams are fully retained inside the vagina, resulting in non leakage and enhanced efficacy.

"It seems the majority of women are dissatisfied with the current intravaginal treatment options. Treatment inconvenience is known to result in poor treatment compliance and there is therefore still a need for new drug delivery systems that can be easily administered, enable adherence of drugs to the vaginal surface and do not leak out or cause irritation," says Arie Yeshaya, M.D., Senior Gynecologist at Rabin Medical Center, Israel (affiliated with Sackler School of Medici
'/>"/>

SOURCE Foamix Ltd
Copyright©2008 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2

Related biology technology :

1. Reclast(R) Receives US FDA Approval as First and Only Once-Yearly Treatment for Women With Postmenopausal Osteoporosis
2. Panel to Discuss the Far-Ranging Effects and Consequences of Heart Disease, Which is the Leading Killer in Both Men and Women in the United States
3. KGI and Smith College Establish Leadership Forum for Women in Bioscience
4. Study Data Results Showed Desvenlafaxine Significantly Reduced Moderate to Severe Vasomotor Symptoms in Menopausal Women Versus Placebo
5. ABCs Private Practice Inaccurately Portrays Serious Womens Health Condition
6. National Survey Shows Most Women Are Not Satisfied With Their Progesterone Treatment
7. Federally-Funded Study Shows More Women Can Avoid Hysterectomy for Common Problem
8. Georgia Reproductive Specialists is First in Southeast to Offer Pioneering Test of Womens Biological Clock
9. Barr and Ortho Womens Health & Urology in Discussions to Settle ORTHO TRI-CYCLEN(R) LO Patent Litigation
10. Collaboration Sparks Creation of New Grand Rapids Laboratory Focused on Womens Health
11. deCODE Discovers Gene Variants that May Help to Distribute the Work of Evolution between Men and Women
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/1/2008)...-FirstCall/ -- Cell Therapeutics, Inc. (CTI),(Nas...ood and Drug,Administration (FDA) has accepted fo...iew status for, the supplemental Biologics License...ibritumomab tiuxetan) as consolidation,therapy fo...mphoma who achieve,a response to first-line thera...
(Date:11/28/2008)...ire/ -- Oncology focused biopharmaceutical,compan...i, M.D., Professor of,Clinical Immunology at the ...,continuing their collaboration on ATIR(TM), a pr...e of a mismatched donor in a bone marrow transplan...ase (GvHD) for end stage leukemia,patients. Under...
(Date:11/28/2008)...homas Wellner, President and CEO of Therapure Biop...gned a biomanufacturing services agreement with Mi...r the production of an iron chelating agent used i... disorder. , Toronto, ON ...ent and CEO of Therapure Biopharma Inc. today anno...
(Date:11/27/2008)...erywhere in our modern world, largely due to prope... but lightweight and easily workable. One of their...end rather than break when put under stress - is a...cribed as "plastic flow", allows many plastics to ... apart, says University of Wisconsin-Madison chemi...
Breaking Biology Technology:FDA Accepts Cell Therapeutics' Zevalin sBLA and Grants Priority Review 2FDA Accepts Cell Therapeutics' Zevalin sBLA and Grants Priority Review 3FDA Accepts Cell Therapeutics' Zevalin sBLA and Grants Priority Review 4FDA Accepts Cell Therapeutics' Zevalin sBLA and Grants Priority Review 5Kiadis Pharma Announces Continued Collaboration With Professor Velardi on its Lead Product ATIR(TM) 2Therapure Biopharma Inc. Announces Manufacturing Agreement with Biomedical Frontiers Incorporated -- Contract will Support Phase II Trials for Thalassemia Treatment 2Therapure Biopharma Inc. Announces Manufacturing Agreement with Biomedical Frontiers Incorporated -- Contract will Support Phase II Trials for Thalassemia Treatment 3Fast molecular rearrangements hold key to plastic’s toughness 2Fast molecular rearrangements hold key to plastic’s toughness 3
.... , a data quality solutions provider, announced t...logics Information Quality Suite to work with Orac...is a business intelligence integration design tool... users to design their business intelligence appli...ng is invoked on critical customer information , ,...
... and Chemicon International, Inc. announced tod...se and apply Madison-based Promegas DNA-directed, ...e agreement, Chemicon, California-based division o... use the technology to develop and sell ddRNAi-bas.... Promega will also provide Chemicon with propriet...
...ologies Inc. announced Tuesday that its genetic a...ssfully extended to chromosomal analysis, opening ...th this important extension of the Invader technol... providing Invader analyte-specific reagents (ASRs...ity of California, Los Angeles, Calif. and other l...
...tion focused on the effects of outsourcing technol...edding some light on the issue. Whatever the produ...to cheaper labor. The effects of this are hurting ...lives. It doesnt matter what you are making, wheth...ntain technology support call centers, write code ...
Other Biology Technology:Offshore outsourcing affects American workers 2Offshore outsourcing affects American workers 3
(Date:11/30/2008)...Like tuning a violin to produce strong, elegant no...d multiple receptors on the outside of the body,s ...be selectively targeted to keep the cells in super...n a study published online November 30 in Nature ...ery of seven different receptors on T cells that c...
(Date:11/27/2008)...ommon genetic polymorphisms induce major different...lation, according to a paper published November 28...nternational team of researchers, led by Karsten S...y with metabolomics, identifying genetic variants ...sulting differences in metabolic capacity can affe...
(Date:11/27/2008)...Scientists at St. Jude Children,s Research Hospita...he cancer cells of children with acute lymphoblast...offers a pathway to designing treatments for ALL r... The most common childhood cancer, ALL affects tho...Although more than 80 percent of ALL cases are cur...
(Date:11/26/2008)...The Wildlife Conservation Society, the Government ...to create a new national park to help protect the ... gorilla. , The park now forms part of an import...ross River National Park, safeguarding an estimate...opulationalong with other rare species. Trans-boun...
Breaking Biology News(10 mins):Wistar scientists find key to keeping killer T cells in prime shape for fighting infection, cancer 2Wistar scientists find key to keeping killer T cells in prime shape for fighting infection, cancer 3Study identifies genetic variants giving rise to differences in metabolism 2St. Jude identifies genomic causes of a certain type of leukemia relapse 2St. Jude identifies genomic causes of a certain type of leukemia relapse 3New national park protects world's rarest gorilla 2New national park protects world's rarest gorilla 3Cardiovascular Technologies to be Highlighted at 5th Annual Cleveland Clinic Medical Innovation Summit Oct 1 3 590 1Cardiovascular Technologies to be Highlighted at 5th Annual Cleveland Clinic Medical Innovation Summit Oct 1 3 590 2Cardiovascular Technologies to be Highlighted at 5th Annual Cleveland Clinic Medical Innovation Summit Oct 1 3 590 3Environmental stress probed in cardiovascular disease diabetes 588 1Environmental stress probed in cardiovascular disease diabetes 588 2Skin oil ozone interactions worsen air quality in airplanes 270 1Skin oil ozone interactions worsen air quality in airplanes 270 2Alzheimers Patients May Suffer Silent Seizures 587 1Alzheimers Patients May Suffer Silent Seizures 587 2
...s 34 regions worldwide where 75 percent of the pla...ns survive within habitat covering just 2.3 percen...e combined areas of the five largest U.S. states)....he Earth,s surface, an area equivalent in size to ...ows that an estimated 50 percent of all vascular p...
...ed today at its 2005 international symposium on Co...,s Human Proteome Folding Project launched on IBM,...y predicted 50,000 protein structures. , "This pro...s," stated Dr. Richard Bonneau, senior scientist a...rtnership with IBM we are utilizing World Communit...
...rotein is critical in the cellular export of iron ...hers report in the March issue of Cell Metabolism.... to 300 people in Western populations --causes tis...eft untreated, the hereditary disease can lead to ... at the Children,s Hospital Boston and Harvard Med...
...eam, led by John W. Lough, Ph.D., professor of cel... embryonic stem cells (ES cells) in animals can be...ay help doctors learn how to replace tissue damage...for ES cells to replace damaged or diseased cells ... in their therapeutic application. Dr. Lough’s res...
Other Biology News:Biodiversity hotspots identify conservation priorities 2Biodiversity hotspots identify conservation priorities 3Biodiversity hotspots identify conservation priorities 4Biodiversity hotspots identify conservation priorities 5Institute for Systems Biology Symposium Addresses Need for Better Computational Tools 2Iron exporter revealed that may explain common human disorder 2Iron exporter revealed that may explain common human disorder 3Stem Cell Research Shows Potential for Replacing Tissue Damaged in Heart Attacks 2
Human Osteocalcin (1-22) mature form. Also reacts with Osteocalcin (1-44) and Osteocalcin (1-49). No reactivity with Bone sialoprotein.
Myt 1 (N-17)
Request Info
...) amide (GLP-1), C-terminal reactive. Cross-reacts...s reactivity with the unamidated forms GLP-1(7-37)... hGLP-2, glucagon, hGIP and VIP.,SPECIES REACTIV...in all mammalian species studied except guinea pig...
Biology Products: